RecruitingNCT02306096

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

SCAN-B: The Sweden Cancerome Analysis Network - Breast Initiative


Sponsor

Lund University

Enrollment

20,000 participants

Start Date

Aug 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.


Eligibility

Plain Language Summary

Simplified for easier understanding

This trial is collecting and studying genetic (genomic) profiles from breast cancer tumors across Sweden to build a large research database. The goal is to give scientists and doctors a detailed picture of the genetic differences between breast cancers, which could lead to better, more personalized treatments in the future. **You may be eligible if...** - You have a suspected or confirmed diagnosis of primary breast cancer (meaning breast cancer that has not spread from another location) - You are willing and able to sign the informed consent form to allow your tissue and data to be used for research **You may NOT be eligible if...** - You have not signed the informed consent form agreeing to participate - Your breast cancer is a recurrence rather than a newly identified primary tumor (discuss with your doctor) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(9)

Hallands Hospital Halmstad

Halmstad, Sweden

Helsingborg Hospital

Helsingborg, Sweden

Kirurgiska kliniken

Jönköping, Sweden

Blekinge County Hospital

Karlskrona, Sweden

Central Hospital Kristianstad

Kristianstad, Sweden

Skåne University Hospital

Lund, Sweden

Skåne University Hospital

Malmö, Sweden

Uppsala University Hospital

Uppsala, Sweden

Central Hospital Växjö

Vaxjo, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02306096


Related Trials